When conducting market intelligence in the healthcare and pharmaceutical sectors, you need access to the right information, as well as a way to separate relevant insights from extraneous noise. Staying ahead in this space means being the first to know of regulatory activities, new drug approvals, clinical trial pipelines, disease landscapes, BD&L, and commercialization decisions.
Pharma market intelligence tools help turn fragmented scientific, clinical, regulatory, and financial data into actionable strategic decisions. By centralizing disparate sources in one AI-powered, searchable platform, these tools dramatically expedite the speed and enhance the quality of research. For pharma organizations, this means faster reaction times, tightened diligence cycles, reduced competitive risk, optimized positioning, and ultimately, smarter investment decisions.
Below, we discuss some of the top pharma market intelligence platforms in 2026, each of which offers a unique value proposition and specialization, from structured clinical and forecasting datasets to real-time competitive monitoring. We cover each tool’s key features, strengths and weaknesses, and pricing to help you choose the right platform for your business needs.
IQVIA
Best for: Commercial performance analytics, real-world evidence, and market forecasting
IQVIA is one of the largest global life sciences data, analytics, technology, and services companies supporting enterprise-level pharmaceutical, biotech, and healthcare organizations. It integrates clinical research, commercial analytics, real-world evidence, and technology infrastructure to help teams accelerate drug development and optimize commercial performance.
IQVIA is strongest in quantitative healthcare data and offers massive proprietary datasets spanning 1.2 billion non-identified patient records.
IQVIA excels where complex, large-scale data and analytics are needed to inform decisions about:
- Commercial strategy and forecasting
- Brand performance and HCP engagement
- Real-world evidence and outcomes research
- Clinical development optimization and evidence generation
- Integrated decision intelligence across functions
The platform is much less focused on unstructured qualitative data, which means some users may want a complementary platform (such as AlphaSense) with content — such as earnings transcripts, broker reports, and expert calls — that can provide the “why” behind a specific insight.
IQVIA’s key features and capabilities include:
Comprehensive Healthcare Data and Real-World Evidence
IQVIA’s healthcare database is one of the world’s largest, spanning:
- Claims and EMR data
- Prescription and patient journey data
- Longitudinal patient records in multiple geographies
These datasets support epidemiology, outcomes research, market measurement, and treatment patterns. If your company is launching a drug and needs to know which doctors are prescribing a competitor’s medication, how many patients are switching therapies, or what the local market share is in a specific zip code, IQVIA will have the data you’re looking for.
Additionally, IQVIA’s real-world evidence is highly useful for proving drug value to regulators and payers. It links disparate data sources (EMR, claims, labs) to create longitudinal patient journeys that clinical trials alone cannot capture.
Integrated Data Management and Analytics Platforms
IQVIA provides a suite of interconnected data infrastructure and analytics solutions designed to ingest, harmonize, govern, and analyze complex healthcare and commercial data at scale.
This integrated approach means organizations can unify large, heterogeneous datasets and apply analytics consistently across both clinical and commercial functions while supporting both self-service and enterprise-level analytic needs.
Commercial and Customer Engagement Solutions
IQVIA offers solutions to support commercial execution and customer engagement, such as:
- CRM and engagement systems
- Content management for regulated promotional materials
- Territory and incentive management tools
Through its Orchestrated Customer Engagement and partnership with Salesforce, IQVIA tracks doctor-level prescribing history and orchestrates sales rep activity. In 2025, IQVIA began allowing its data to flow natively into Veeva’s CRM, cementing its status as the industry's data backbone.
AI Capabilities
IQVIA has developed a purpose-built AI framework called Healthcare-grade AI™ that’s designed specifically for life sciences and healthcare use cases due to its precision, domain specificity, regulatory compliance, patient privacy, and scientific rigor. This framework also incorporates machine learning to drive predictive analytics, as well as natural-language processing (NLP) to extract structured data from unstructured records.
Specific AI features included in the IQVIA platform include:
IQVIA AI Assistant
This is a generative AI-based conversational AI feature embedded into IQVIA analytics tools, which allows users to ask natural-language questions such as, “What’s driving prescription growth this quarter?” or, “How is brand performance trending in this geographic region?” Users then receive quick, accurate insights straight from IQVIA’s datasets.
Agentic Workflows
These are autonomous, purpose-built workflows designed to accelerate complex life sciences processes, such as clinical operations acceleration, trial execution support, and commercial workflow optimization.
Agentic AI helps automate entire workflows rather than just individual tasks, which can meaningfully shorten timelines in ways traditional analytics cannot.
IQVIA Pros:
- One of the largest and most comprehensive global healthcare datasets
- Combines clinical, commercial, and real-world insights in a unified ecosystem
- Proprietary AI framework purpose-built for life sciences use cases
- End-to-end life sciences support across the full product lifecycle
- Incorporates self-service analytics
- Enterprise-grade infrastructure with heavy investment in data privacy and governance
IQVIA Cons:
- Limited availability of qualitative insights means users need supplementary platform to reveal full strategic context
- No broker reports to help pharma leaders understand how the market is interpreting clinical, regulatory, and competitive developments
- No earnings call transcripts that reveal strategic priorities, commercial expectations, capital allocation decisions, and emerging risks directly from company leadership
- No expert call transcripts featuring KOLs, former regulators, and industry specialists that provide deeper interpretation of clinical data, trial design, regulatory dynamics, and standard-of-care shifts
Cortellis
Best for: Deep pipeline, clinical, regulatory, and R&D intelligence
Developed by U.K. analytics firm Clarivate, Cortellis is a comprehensive life sciences intelligence platform that has cemented its role as the industry's leading source for the "compliance and creation" phases of a drug’s development. It is deeply embedded in the life sciences sector, utilized by each of the top 20 global pharmaceutical companies.
Cortellis integrates disparate information (patents, clinical trials, regulatory filings, deals, targets, safety data, and more) into a unified platform designed to accelerate evidence-based decisions in pharma and biotech. It is best suited for R&D scientists, regulatory affairs professionals, clinical operations professionals, and IP attorneys.
Cortellis is built on structured datasets, making it a useful tool for looking up specific technical facts, such as a drug's exact mechanism of action, patent expiration date, or current trial phase. The platform’s focus on structured data means a complementary platform like AlphaSense is needed for content such as earnings transcripts, broker reports, and expert calls.
Cortellis’s key features include:
Deep Curated Data
Cortellis data is manually curated by Ph.D.-level scientists and enriched with disease-specific taxonomies. Built-in datasets include:
- Comprehensive global drug pipeline data, including assets in discovery through post-approval
- Detailed clinical trial intelligence, including study design, endpoints, timelines, sponsors, and geographies
- Global regulatory tracking, including approvals, designations, and guidance updates
- Patent and generics intelligence, including exclusivity timelines and Paragraph IV activity
- Curated deal and licensing data, with structured terms and transaction insights
Because the data spans across assets, indications, companies, and geographies, users can benchmark competitors, analyze therapeutic landscapes, and assess portfolio risk with confidence.
Specialized Modules
Cortellis is separated into several deep-dive modules that each focus on a different set of use cases. These modules include:
- Competitive Intelligence and Portfolio Strategy – Monitor competitor pipelines, assess probability of success, model timelines, and benchmark portfolios.
- Clinical and Regulatory Intelligence – Track global trials, analyze protocol design, and anticipate regulatory milestones or hurdles.
- Discovery and Preclinical Intelligence – Evaluate targets, mechanisms of action, and translational data to inform early-stage R&D prioritization.
- Deals and Generics Intelligence – Benchmark licensing structures, track M&A activity, and anticipate lifecycle threats.
- Safety and Systems Biology – Analyze toxicity, pathway interactions, and biological networks to reduce risk in development.
This modular approach enables users across R&D, business development, regulatory, and competitive intelligence teams to work from a shared data backbone while focusing on their domain-specific priorities.
AI Capabilities
Cortellis incorporates AI and advanced analytics to enhance discovery and decision-making across its datasets.
AI capabilities include:
- Predictive modeling of probability of technical and regulatory success
- Automated data harmonization and entity linking across assets, companies, and indications
- Intelligent alerts and monitoring across selected drugs, competitors, and therapy areas
- Enhanced search and filtering capabilities to accelerate complex landscape analysis
While Cortellis’ AI is primarily focused on structured data modeling and predictive analytics rather than generative summaries or conversational AI, it significantly reduces manual research time and improves confidence in portfolio and competitive decisions.
Cortellis Pros:
- Robust database covering over 800,000 drugs and biologics, 700,000 clinical trials, 3 million drug safety alerts, and 300,000 regulatory documents
- Organizations can purchase specific modules rather than the full suite
- Robust regulatory intelligence
- Robust patent intelligence
- Includes AI-driven predictive and analytical capabilities
Cortellis Cons:
- Primarily structured data with limited narrative context
- Modules result in some data fragmentation
- No generative AI or sentiment analysis
- No broker reports to help pharma leaders understand how clinical, regulatory, and competitive developments are being interpreted by the market
- No earnings call or expert call transcripts
Evaluate
Best for: Drug pipeline valuation, consensus sales forecasting, and risk-adjusted portfolio decision-making
Evaluate is the leading tool for valuation and forecasting in the pharmaceutical space and is considered the industry standard for consensus forecasts. If you need to build a business case for an acquisition or justify an R&D budget to a board of directors, Evaluate is the right tool. Evaluate is best for working with structured quantitative datasets, meaning a complementary platform is needed for additional context.
Evaluate includes the following key features:
Deep Commercial and Forecast Intelligence
Evaluate’s core strength lies in its standardized commercial performance data and consensus sales forecasts across the global pharmaceutical market. Built-in datasets include:
- Consensus sales forecasts aggregated from leading equity analysts
- Historical commercial performance data across products, companies, and therapy areas
- Linked pipeline-to-market views that connect assets to projected commercial outcomes
- Therapy area and indication-level market sizing
- Company-level benchmarking and revenue concentration analysis
Armed with these datasets, teams can quickly compare commercial potential, rank opportunities, and assess competitive positioning with consistency.
Specialized Modules and Analytical Workflows
Evaluate is designed with several key modules, each with a slightly different focus and set of use cases. These modules include flagship products such as Evaluate Pharma and Evaluate Omnium, as well as Evaluate Epi, Biomedtracker, Competitive Intelligence, and more.
The key workflows these models support include:
Market Sizing and Forecasting
With its suite of forecasting solutions, Evaluate offers an unmatched view into global pharma markets and enables you to develop informed forecasts on your key assets. Key modules in this use case include Evaluate Pharma, Evaluate Omnium, Evaluate Epi, and Pharma Forecasting.
Business Development and Licensing
Evaluate enables you to compare candidates based on commercial, clinical, and scientific criteria such as market novelty, potential revenue, competitive intensity, and partner suitability. Key modules in this use case include Evaluate Pharma, Evaluate Omnium, BioSciDB, and Biomedtracker.
Portfolio Optimization and Asset Strategy
Evaluate gives you the competitive edge you need to navigate the market’s complexities, optimize your pipeline, develop comprehensive scenario planning, and prioritize the right indications. Key modules in this use case include Evaluate Pharma, Biomedtracker, Datamononitor Healthcare, and Competitive Intelligence.
Competitive Intelligence
Evaluate helps you stay competitive by providing tracking, analysis, and strategic intelligence to support decision-making processes across drug development, manufacturing, and market competition. Key modules in this use case include Competitive Intelligence, Biomedtracker, Evaluate Epi, and Evaluate Pharma.
Consulting and Analytics
Evaluate’s custom analytics team helps you address unique commercial challenges. With access to extensive data assets and experience across therapy areas and modalities, the team partners with you to provide the answers you need to drive success. Key modules in this use case include Custom Analytics, Custom Model Build, and Pharma Forecasting Training.
AI Capabilities
While Evaluate is not a genAI platform, it does incorporate machine learning and predictive analytics to support forecasting, risk/return analysis, and decision modeling within pharma.
Specific capabilities include:
- Consensus aggregation and forecast tracking across multiple analyst models
- Machine learning-driven risk/return scoring for pipeline assets
- Standardized commercial comparables across therapy areas
- Scenario and analog-based modeling to stress-test assumptions
- Ranking and filtering tools for opportunity prioritization
- Intelligent alerts and dynamic analytical tools that help users monitor changes in forecast assumptions, pipeline risk, and competitive landscapes over time
Evaluate Pros:
- Strong consensus forecasting and market sizing capabilities
- Broad pipeline visibility that includes early-phase and private pipeline data
- Enables standardized cross-company portfolio comparisons
- Integrated within Norstella so users can use adjacent tools like Citeline for broader clinical and regulatory intelligence
- Incorporates AI and predictive analytics to support forecasting, risk/return analysis, and decision modeling in pharma
Evaluate Cons:
- Consensus forecasting is dependent on analyst coverage so can be inconsistent
- Primarily structured data with limited qualitative context
- Less clinical depth than R&D-focused platforms like Cortellis
- No genAI or sentiment analysis
- No broker reports to help pharma leaders understand how clinical, regulatory, and competitive developments are being interpreted by the market
- No earnings call or expert call transcripts that reveal strategic priorities, commercial expectations, capital allocation decisions, and emerging risks directly from company leadership
- No expert call transcripts featuring KOLs, former regulators, and industry specialists that provide deeper interpretation of clinical data, trial design, regulatory dynamics, and standard-of-care shifts
GlobalData Pharmaceuticals
Best for: Deep, structured datasets for pharma market sizing, pipeline and forecast modeling, and strategic planning across therapy areas
Contrary to the more specialized platforms on this list, GlobalData Pharmaceuticals is a more holistic, generalist solution. It combines large, integrated datasets, expert analysis, thematic research, and forecasting tools to give users a 360-degree view of drug development, market dynamics, clinical activity, and company strategy.
GlobalData is mostly focused on structured datasets such as drug pipelines, clinical and market data, regulatory milestones. In contrast to many platforms, it also incorporates expert analysis reports, news, and trend commentary. Yet the depth of GlobalData’s qualitative data offerings is still limited, and it lacks advanced AI-driven search and summarization capabilities that are needed to quickly extract the most relevant insights and discover important connections across disparate sources.
As such, GlobalData serves well as a complementary platform to AlphaSense. For example, a pharmaceutical consulting firm could purchase high-value, structured reports and market models from GlobalData and upload them directly into AlphaSense. From there, AlphaSense's AI can synthesize the GlobalData insights alongside external broker reports, medical journals, and internal perception studies (found in the AlphaSense platform), creating a single source of truth for the entire organization.
GlobalData includes the following key features:
Extensive Global Pharma Intelligence
GlobalData aggregates extensive global pharma intelligence across multiple domains:
- Drug profiles and pipeline data across discovery to commercialization, including development stage, mechanism of action, indication, and regulatory status
- Clinical trials intelligence, including ongoing and completed study details like design, endpoints, sponsors, investigators, and results
- Market analysis and forecasts, including market size, growth drivers, competitive dynamics, and therapeutic area trends
- Epidemiology and market size databases with granular patient population forecasts and demographic segmentation
- Company and deal data, including mergers, acquisitions, licensing activity, and competitive positioning
- Regulatory milestones & catalysts mapped to development progress and market impact
Thematic Intelligence and Expert Analysis
GlobalData offers some qualitative insights to provide context to its quantitative data. These include:
- Investigative reports and market commentary synthesizing trends and implications
- Analyst briefings and expert presentations that contextualize data with strategic interpretation
- News and investigative content that highlights emerging risks, opportunities, and competitive moves
Workflow and Research Tools
The platform incorporates practical tools to support research and analysis. These include:
- Custom report builders and dashboards
- Interactive modeling tools
- Automated alerts and monitoring workflows
- Multi-format export and integration options for downstream analysis
Together, these tools help streamline workflows across competitive intelligence, forecasting, and strategic planning.
AI Capabilities
While GlobalData does not have genAI capabilities or advanced AI search, it effectively harnesses AI for predictive analytics. The company’s flagship Likelihood of Approval model uses machine learning to estimate the probability of a drug receiving regulatory authorization. Additionally, GlobalData leverages machine learning and predictive techniques across structured datasets to support:
- Structured trend forecasting and scenario analysis
- Risk stratification of pipeline portfolios
- Modeling of regulatory and clinical success likelihoods
- Enhanced signal detection from historical patterns in structured data
GlobalData emphasizes AI as a strategic enabler to reduce manual workload, highlight patterns, and support quantitative decision making.
GlobalData Pharmaceuticals Pros:
- Broad integrated data that provides a holistic view of the entire pharma lifecycle
- Offers global data across different therapeutic areas, enabling cross-market comparisons and trend analysis
- Incorporates qualitative sources, such as thematic reports, analyst commentary, news feeds, and investigative analysis to add narrative context to quantitative sources
- Incorporates machine learning and predictive analytics for assessing regulatory risk
- Incorporates workflow tools that streamline research processes and facilitate collaboration
GlobalData Pharmaceuticals Cons:
- Many datasets are not available in real time
- Not built for transaction-level market data
- Not built for deep clinical protocol analysis
- No genAI or sentiment analysis
- No broker reports to help pharma leaders understand how clinical, regulatory, and competitive developments are being interpreted by the market
- No earnings call transcripts that reveal strategic priorities, commercial expectations, capital allocation decisions, and emerging risks directly from company leadership
- No searchable expert call transcript library featuring KOLs, former regulators, and industry specialists that provide deeper interpretation of clinical data, trial design, regulatory dynamics, and standard-of-care shifts
DealForma
Best for: Tracking deal activity in the biopharma and medtech sectors
DealForma is a specialized database and analytics platform built for tracking deal activity in the life sciences industry, particularly in biopharma, medtech, and diagnostics. The platform offers detailed structured data on a wide variety of deal types including licensing agreements, mergers and acquisitions, venture financings, IPOs, codevelopment partnerships, and royalty monetizations.
Primarily intended for business development, competitive intelligence, and investment teams, DealForma makes it easy to benchmark deal terms, track competitor activity, and identify emerging trends in dealmaking. However, as a smaller private company, DealForma is lacking in broad data coverage and lags behind in new feature development. Currently, DealForma lacks AI-powered search or NLP capabilities, relying instead on structured search filters.
DealForma’s content centers heavily around deals, drug pipeline and asset data, clinical trials, and regulatory data. It does not offer earnings transcripts, expert call transcripts, or broker research reports. Users also cannot upload their own internal content to DealForma.
For that reason, DealForma lends itself well to a support role alongside a platform like AlphaSense. DealForma provides detailed structured transaction intelligence that AlphaSense then augments with the strategic, financial, and competitive narrative that explains how those deals are interpreted by the market. Together, these platforms connect hard deal data with the broader context needed to make confident business and investment decisions.
DealForma features include:
Comprehensive Deal Database
DealForma offers the following in its deal database:
- Licensing, R&D, and Academic Agreements: Detailed records of partnerships, including financial terms, milestones, and royalties
- M&A, Spin-Outs, and Asset Purchases: Information on mergers, acquisitions, company spin-outs, and asset transactions
- Deal Comparables and Financial Metrics: Structured data enabling users to benchmark deals by stage, modality, therapy area, target, and territory
- Contracts and Press Releases: Access to original source documents and official announcements for each deal
Funding and Investment Tracking
DealForma provides data on private and public funding rounds for life sciences companies, including investor details and amounts raised. It also provides profiles of private equity and venture capital investors, detailing their investment activities and portfolios.
Company and Asset Profiles
DealForma provides comprehensive profiles encompassing company overviews, financials, and strategic activities for global biotech, pharma, medtech, digital health therapeutics, and diagnostics firms. It also provides insights into investment firms specializing in the life sciences sector.
Drug Pipelines and Sales Data
DealForma offers the following information on drug pipelines and sales:
- Data on drug discovery platforms and compounds in pre-clinical or early clinical stages
- Information on approved drugs, including labeling and marketing details
- Sales performance data and launch timelines for pharmaceutical products
- Tracking of clinical development stages and regulatory approvals
- Specifics on how drugs are administered, their dosages, and formulations
Advanced Search and Filtering
With its granular filters, DealForma allows users to filter data by stage of development, indication, modality, target, geography, and more — all using natural-language queries. DealForma does not offer AI or genAI search capabilities for more sophisticated querying capabilities.
Interactive Dashboards and Analytics
DealForma offers market analytics dashboards: pre-built charts and reports for market trends, licensing landscapes, and funding activities. DealForma also integrates with Tableau to provide interactive charts and visuals, customizable by therapy area, modality, trial stage, and more.
Analyst Support
All subscribers receive support from analysts to assist with data interpretation, perform custom analyses, and provide insights tailored to specific business needs.
Export and Reporting Tools
DealForma offers the ability to generate reports with AI summaries and export tools. DealForma supports data downloads in various formats, including Excel, PDF, and CSV, but does not support internal data uploads.
DealForma Pros:
- Highly specialized focus on life sciences
- Comprehensive and structured deal data on various deal types
- High-quality data updated in real time
- Intuitive search and filtering capabilities
- Interactive and customizable dashboards, charts, and visuals
- Dedicated analyst support for data interpretation, custom analyses, and report generation
DealForma Cons:
- Limited to life sciences; not usable for deal analysis in broader industries
- No expert call transcripts
- No broker research reports
- No earnings transcripts
- No AI, genAI, or NLP search capabilities
- Limited collaboration tools; no internal document integration or annotation capabilities
- Data sourcing may require occasional manual validation if using for investment-grade analysis
AlphaSense
Best for: Enhancing the value of pharma databases through integration, AI capabilities, and additional external qualitative and quantitative sources that provide key context
AlphaSense differs from all other tools on this list, as it is not a pharmaceutical database, nor is it intended only for life sciences customers. Instead, it is an AI-driven market research platform that offers a centralized library of premium and proprietary content sets, extensive quantitative data, and AI capabilities for both real-time monitoring and historical research. AlphaSense is ideal for pharma organizations that want to layer real-time qualitative insights and market context on top of traditional pharma data to enable faster, more confident decision-making.
The benefit of incorporating AlphaSense into your research workflow, whether as a standalone tool or as a complement to a traditional pharma database, is that you get contextual intelligence across the full market narrative — not just drug data.
AlphaSense’s features include:
Premium External Market Intelligence
AlphaSense provides access to differentiated content that helps teams interpret what clinical and regulatory developments mean in practice:
- Broker reports from top Wall Street firms that help pharma leaders understand how clinical, regulatory, and competitive developments are being interpreted by the market
- Earnings call transcripts and management commentary that reveal strategic priorities, commercial expectations, capital allocation decisions, and emerging risks directly from company leadership
- Expert call transcripts featuring KOLs, former regulators, and industry specialists that provide deeper interpretation of clinical data, trial design, regulatory dynamics, and standard-of-care shifts
- News and regulatory coverage to proactively monitor emerging risks and competitive moves
AlphaSense also provides cross-industry intelligence spanning biotech, healthcare services, diagnostics, medtech, and macroeconomic trends that surfaces external forces — from pricing pressure to policy shifts to capital markets dynamics — that materially impact pharma strategy.
Integrated Internal Data
Users can also integrate and query their own internal content in AlphaSense alongside the premium external sources listed above. This means pharma decision-makers can analyze their internal research, investment memos, and third-party reports alongside external intelligence found in the platform. This creates a unified research environment where clinical, financial, and strategic perspectives can be analyzed together.
Financial Data
AlphaSense provides access to the following crucial quantitative insights:
- Historical Financials & Estimates: Standardized statements and consensus data across 19,000+ public companies
- Sector-Specific KPIs: Detailed operating metrics sourced from institutional-grade Canalyst models
- Transaction Intelligence: Details on nearly 1 million M&A deals and 750,000 private funding rounds, enriched with AI-generated deal rationale and strategic context
- Dynamic Peer Sets: 125+ pre-built industry comparables with sector-specific metrics
AI Search and Summarization Technology
AlphaSense’s AI features help users extract crucial insights from each data source, enabling you to reduce research time, anticipate competitive moves earlier, and make faster, more confident strategic decisions.
Generative Search
With Generative Search, you can ask natural-language questions and source intelligence at scale from specific sources, including ClinicalTrials.gov, FDA, EMA, and PubMed — or from across our entire aggregated library of content. Generative Search will instantly return citable, verifiable answers, and you can dive deeper into each topic by asking follow-up questions or clicking into the source.
You can also take Generative Search on the go with our mobile app, giving you access to instant answers, wherever you work.
Generative Grid
Generative Grid applies multiple genAI prompts to many documents at the same time to quickly provide organized answers to research questions at scale, in an easy-to-read table format. Generative Grid pulls data from both premium external documents in the AlphaSense platform and users’ internal content. Users can leverage this tool to track clinical trials, compare competitors at a glance, parse through medical studies in seconds, track biopharma deal activity, or analyze merger proxy filings, among many other use cases.
Smart Summaries
Every earnings transcript in AlphaSense features an AI-generated Smart Summary, which creates a tearsheet of key takeaways, analyst Q&A, and the most critical topics discussed in each call. Pharma professionals can use Smart Summaries to instantly extract key insights from competitors’ earnings transcripts.
Sentiment Analysis
Sentiment analysis, an NLP-based feature, parses content and identifies nuances in language such as tone and subjective meaning. It then uses color coding to help users identify instances of positive, negative, and neutral sentiment throughout the document.
Monitoring, Analysis, and Collaboration Tools
AlphaSense is designed to help users uncover insights faster with the following tools:
- Customizable dashboards create a centralized information hub for monitoring key companies and themes, while tailored alerts provide real-time updates.
- Powerful collaboration tools like Notebook and commenting features help teams manage and share insights more effectively.
- Table Tools allow you to move faster with spreadsheet-style visualizations directly from company filings, so you can chain together, edit, and optimize tables for analysis.
- Image Search allows you to discover insights buried in charts to quickly return data without reading through pages of documents.
- Snippet Explorer allows you to effortlessly assess any topic or theme and all its historical mentions in a single view.
- A mobile app that lets you track real-time alerts and run AI searches on the go, ensuring you never miss a critical insight.
- Automated Monitoring allows you to set up real-time alerts that send instant updates on any relevant market movements, news, emerging trends, and competitor activities. We also generate snapshots of companies and topics regularly that keep you ahead of the curve with actionable insights.
AlphaSense Pros:
- Extensive content database that spans key market perspectives, including broker research, expert calls, company documents, news, and regulatory sites
- Extensive quantitative insights and financial data workflow and analysis tools
- AI and genAI tools that users can apply to integrated internal content alongside platform content
- 4,500+ pre-built financial models that update automatically
- Live transcripts that allow users to view past, present, and future event transcripts in a calendar and view event transcripts in real time
- Automated and customizable real-time alerts
- All-in-one research platform
- User-friendly interface
- Internal note-taking, sharing, and collaboration features
- Support for APIs and integrations
- Supports enterprise-level organizations and teams
- A mobile app designed for on-the-go workflows, providing access to our full content library, generative search, and alerts
- Excellent customer support team, including 24/7 chat with product specialists, a Live Help button on the website, and regular live AlphaSense Education webinars
AlphaSense Cons:
- Visualization tools are limited at this time
- Collaboration tools are limited to users with AlphaSense licenses
Choosing the Right Pharma Market Intelligence Platform
When considering a pharma market intelligence platform, every organization should be asking questions throughout the process, such as:
What types of data and content are available through the platform? Pharma intelligence platforms vary significantly in scope. Some focus heavily on structured datasets, such as drug pipelines, clinical trials, regulatory milestones, epidemiology, pricing, and sales forecasts. Others provide qualitative content, such as broker research, earnings call transcripts, expert interviews, and industry news. Additionally, some platforms allow you to upload your own internal data and analyze it alongside external content sets, while others lack this capability. Consider what data types are most critical to your market intelligence workflow.
Is the platform built for pharmaceutical workflows? Pharma market intelligence involves specific use cases like benchmarking and monitoring your competitive landscape, market landscaping and opportunity sizing, industry assessment and early-stage due diligence. Make sure you choose a platform that streamlines all these workflows and reduces manual effort.
Does the platform offer advanced AI capabilities? AI has become a major differentiator in pharma market intelligence platforms, but capabilities vary widely. Some platforms only use AI for predictive analytics, while others have a more robust generative AI suite with conversational and summarization capabilities. Ensure your chosen platform incorporates AI in a way that meaningfully accelerates and enhances your research process.
Does the platform integrate into your broader intelligence stack? Most pharmaceutical teams use multiple tools — for CRM, forecasting, business intelligence, regulatory tracking, and internal knowledge management. Ensure your chosen platform seamlessly integrates with the tools you are already using and ideally, that it helps you get even more value from your existing intelligence stack.
Could you benefit from more than one platform? Because most of the platforms on this list lean quantitative, it can be highly beneficial to pair them with a robust qualitative research platform like AlphaSense. With our premium and proprietary content sets, as well as AI features like Generative Search and Generative Grid, we help you get the most value from each quantitative insight and understand the context behind every number — giving you the competitive edge. For many life sciences organizations, the strongest intelligence strategy is not choosing one tool — but building a connected stack that supports both quantitative rigor and contextual interpretation.
Try AlphaSense for Free
AlphaSense supports pharmaceutical workflows end-to-end with our extensive library of premium and proprietary content, generative search and AI capabilities, real-time alerts, and custom dashboards.
For pharma professionals looking to elevate their market research strategies and get a competitive edge, AlphaSense offers a free two-week trial of its platform. Discover why 92% of the largest pharmaceutical companies use AlphaSense.
